Concepedia

Hussien Al‐Shamma

HA

Statistics

Publications

21

Citations

1.1K

H-Index

16

Active since

1990

Affiliations

Arena Pharmaceuticals (United States)(Current)

University of California, Los Angeles

University of Massachusetts Amherst

Department of Physiological Sciences

Hussien Al‐Shamma is an author at Arena Pharmaceuticals (United States) specializing in pharmacology, medicine, and medicinal chemistry.

Publications per year

1990–2019

21

Publications

21

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 402 citations

, , +14

Sex differences in hormonal responses of vasopressin pathways in the rat brain

Geert J. De Vries, Hussien Al‐Shamma · Journal of Neurobiology · 1990 · 130 citations

, , +17

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

, , +17

Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis

Karin Przyklenk, Andrew L. Frelinger, Matthew D. Linden et al. · Journal of Thrombosis and Haemostasis · 2009 · 60 citations · Full text

, , +17

The Selective Sphingosine 1-Phosphate Receptor Modulator Etrasimod Regulates Lymphocyte Trafficking and Alleviates Experimental Colitis

Hussien Al‐Shamma, Karin Lehmann‐Bruinsma, Christopher J. Carroll et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 50 citations · Full text

, , +17

1–5 of 21